Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/28/2008WO2008101724A1 Use of riboflavin in the treatment of hypertension
08/28/2008WO2008101723A2 Pharmaceutical composition containing a cholesterol absorption inhibitor
08/28/2008WO2008101707A1 Low glycemic mixtures
08/28/2008WO2008101693A2 Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds
08/28/2008WO2008101692A2 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline
08/28/2008WO2008101665A1 Macrocyclic compounds as hcv ns3 protease inhibitors
08/28/2008WO2008101660A1 Spirocyclic cyclohexane derivatives
08/28/2008WO2008101659A1 Spirocyclic cyclohexane derivatives
08/28/2008WO2008101591A1 Novel methods
08/28/2008WO2008101587A1 4-(pyrrolopyridinyl)pyrimidin-2-ylamine derivatives
08/28/2008WO2008101586A1 Benzimidazole derivatives
08/28/2008WO2008101554A1 Pellets comprising an active substance matrix and a polymer coating, and a method for producing said pellets
08/28/2008WO2008101514A1 Nucleoside analogues for the treatment of viral infections and methods for preparing them
08/28/2008WO2008101412A1 The use of epimedium flavones and effective components thereof for the preparation of medicaments of promoting proliferations and differentiations of nerve cells
08/28/2008WO2008101375A1 A gastric retentive sustained-release pharmaceutical composition comprising irbesartan
08/28/2008WO2008101354A1 Gpr65 as a therapeutic target in allergic airway inflammation
08/28/2008WO2008101344A1 Soluble bioactive lipophilic compounds compositions
08/28/2008WO2008101313A1 Preparation of amino acid-fatty acid amides
08/28/2008WO2008101266A1 Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6h-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof
08/28/2008WO2008082602A3 Compounds and pharmaceutical compositions for the treatment of liver disorders
08/28/2008WO2008082537A3 Compounds for modulating integrin cd11b/cd18
08/28/2008WO2008081399A3 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
08/28/2008WO2008080542A3 Combination product for controlling parasites on animals
08/28/2008WO2008080120A3 3-amino chromane derivatives
08/28/2008WO2008079683A3 N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
08/28/2008WO2008079312A3 Compositions for treatment of nasal congestion
08/28/2008WO2008079256A3 Methods for treating nasal congestion in hypertensive or diabetic patients
08/28/2008WO2008078096A3 Medicaments and methods for promoting wound contraction
08/28/2008WO2008076804A3 Method of treating intrauterine inflammation
08/28/2008WO2008076779A3 2-(piperidin-4-yl0xy)pyrimidin-4-amine derivatives as deoxycytidine kinase inhibitors for the treatment of cancer
08/28/2008WO2008074833A3 Compounds
08/28/2008WO2008073785A3 Phosphoinositide 3-kinase inhibitor compounds and methods of use
08/28/2008WO2008073450A3 Benzamide compounds
08/28/2008WO2008072985A3 Pour on formulation
08/28/2008WO2008071766A3 Spiro-indene substituted imidazonaphythyridine and pyranoimidazopyridine derivatives as inhibitors of gastric acid secretion
08/28/2008WO2008070831A3 Bisbenzamidines and bisbenzamidoximes for the treatment of human african trypanosomiasis
08/28/2008WO2008070305A3 1, 5-diphenyl-3-pyridinylamino-1, 5-dihydropyrrolidin-2-one as cbl' receptor modulator
08/28/2008WO2008070041A3 Inhibitors of akt activity
08/28/2008WO2008066745A9 Prophlyaxis and treatment of atrial fibrillation with omega-3 fatty acids
08/28/2008WO2008065666A3 Uses of incensole, incensole acetate and derivatives thereof
08/28/2008WO2008064734A3 Medicament with controlled release containing galanthamine
08/28/2008WO2008063857A3 Antioxidant dietary supplement compositions and methods for maintaining healthy skin
08/28/2008WO2008063513A3 Selective proteasome inhibitors for treating diabetes
08/28/2008WO2008063504A3 Cyclohexenyl-aryl compounds for inflammation and immune-related uses
08/28/2008WO2008060787A3 Methods for treatment of cochlear and vestibular disorders
08/28/2008WO2008060515A3 Topical compositions comprising polyhydroxy acids and/or lactones for improved cutaneous effects of oxidative therapeutic drugs
08/28/2008WO2008059513A3 Compounds suitable as modulators of hdl
08/28/2008WO2008058288A3 Sustained release methotrexate formulations and methods of use thereof
08/28/2008WO2008058236A3 Methods for preparing cinacalcet hydrochloride
08/28/2008WO2008057496A3 Method for treating delirium
08/28/2008WO2008056202A3 Desloratadine crystalline forms mixtures having a low level of residual solvents
08/28/2008WO2008052190A3 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
08/28/2008WO2008051637A3 Pyridazinone compounds
08/28/2008WO2008050344A3 Treatment of hepatic encephalopathy and liver cirrhosis
08/28/2008WO2008048574A3 Hca for improved hdl serum lipids profile
08/28/2008WO2008047364A3 Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
08/28/2008WO2008045961A3 Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices
08/28/2008WO2008043461A3 Inhibition of pde2a
08/28/2008WO2008042973A3 Lipid containing formulations
08/28/2008WO2008042773A3 Unitary pharmaceutical composition, method, and kit for the treatment or prevention of metabolic or endocrine disorders
08/28/2008WO2008040792A3 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
08/28/2008WO2008039489A3 5-substituted quinazolinone derivatives as antitumor agents
08/28/2008WO2008033891A3 Azonafide derived tumor and cancer targeting compounds
08/28/2008WO2008033851A3 Use of 2-6- (3-amino-piperidin-l-yl) -3-methyl-2, 4-dioxo-3, 4-dihydr0-2h-pyrimidin-1-ylmet hyl-4-fluoro-benzonitrile
08/28/2008WO2008031032A3 Compounds for and methods of treating insulin resistance and inflammation
08/28/2008WO2008030626A3 Skin compositions containing hydrocortisone
08/28/2008WO2008019823A3 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins
08/28/2008WO2008017278B1 Crystalline tolterodine tartarate and a pharmaceutical composition containing the same
08/28/2008WO2008016730A3 Compositions and methods for reducing cellular fat
08/28/2008WO2008006021A3 Shifter with actuator incorporating shape memory alloy
08/28/2008WO2008005333A3 Use of extended cycle and continuous estrogen contraceptive regimens in the treatment of osteopenia and related conditions in adolescent females
08/28/2008WO2007140253A3 Treatment of hiv-1 by modulation of vpr activation of the m-csf promoter
08/28/2008WO2007137008A3 Compounds for the treatment of metabolic disorders
08/28/2008WO2007134136A3 Neurogenesis by modulating angiotensin
08/28/2008WO2007133820A3 Diaryl triazolones as cb1 antagonists
08/28/2008WO2007121352A3 Therapeutic triterpenoids
08/28/2008WO2007120864A3 Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
08/28/2008WO2007117465A3 Indazole compounds
08/28/2008WO2007102769A3 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
08/28/2008WO2007100623A3 Hydroxylamines and derivatives for the inhibition of complement activation
08/28/2008WO2007098099A3 Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor
08/28/2008WO2007098091A3 Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
08/28/2008WO2007098089A3 Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs
08/28/2008WO2007092720A8 Vitamin d analog: nel, methods and uses thereof
08/28/2008WO2007087488A9 Indole sulfonamide modulators of progesterone receptors
08/28/2008WO2007081696A3 Treating androgen decline in aging male (adam)-associated conditions with sarms
08/28/2008WO2007073497A3 Calcium channel antagonists
08/28/2008WO2007072142A3 Benzimidazole-5-carboxamide derivatives
08/28/2008WO2007070426A3 Sexual dysfunction
08/28/2008WO2007042271A8 Nutraceutical composition for the treatment of muscle wasting
08/28/2008US20080209581 Induction of exon skipping in eukaryotic cells
08/28/2008US20080208354 Solid Precursor For the Preparation of a Pasty Bone Replacement Material By Admixture of a Liquid
08/28/2008US20080208179 Methods of increasing skin permeability by treatment with electromagnetic radiation
08/28/2008US20080208167 Methods and compositions to treat myocardial conditions
08/28/2008US20080208052 Systems and methods for improving image-guided tissue ablation
08/28/2008US20080207883 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes
08/28/2008US20080207773 Cosmetic, pharmaceutical and dermatological products
08/28/2008US20080207771 Topical Compositions
08/28/2008US20080207770 Compositions enriched in phenolic compounds and methods for producing the same
08/28/2008US20080207769 Method for treating benign prostatic hyperplasia
1 ... 3110 3111 3112 3113 3114 3115 3116 3117 3118 3119 3120 3121 3122 3123 3124 3125 3126 3127 3128 3129 3130 ... 7860